Live Educational Webinars

The first & only FDA-authorized video game treatment for inattention in ADHD.

Welcome to EndeavorRx: an interactive, nonpharmacological therapeutic for kids 8-12 with primarily inattentive or combined-type ADHD.

Discover EndeavorRx

In partnership with

The future of digital ADHD therapy

EndeavorRx is the first and only clinically proven prescription video game that specifically targets cognitive processes involved in attention function.

It’s designed to engage key neural systems associated with attentional control in patients with primarily inattentive or combined-type ADHD — delivered through an immersive video game experience inspired by kids’ passion for play.

Discover EndeavorRx

Watch EndeavorRx in action

Wondering what it’s like to play? Watch our gameplay trailer for a preview of the patient experience, or download a 5-minute demo from the App Store® or on Google Play™ to try it for yourself.

Note: This demo experience is intended for informational purposes only. It does not contain the therapeutic EndeavorRx algorithm and therefore is not a substitute for treatment with EndeavorRx.

Download a demo version of the app

Unlock your patients’ potential

FDA authorization supported by 5 clinical studies with over 600 children with ADHD.³

68% of parents reported improvement in ADHD-related impairments after two months of treatment.²

73% of children reported an improvement in their attention.¹

0% There were no serious adverse events seen in any clinical trials of EndeavorRx.3

Explore our research

¹ Kollins et al, Lancet Digital Health 2020. Data from a “Yes-No” Exit Survey.
² STARS-ADHD-Adjunctive: Kollins et al, npj digital medicine, 2021.
³ EndeavorRx Instructions for Use

Prescribing EndeavorRx

Interested in using EndeavorRx in your practice? Here’s what you need to know.

How To Prescribe

Want more information about EndeavorRx?

Just complete the form below to receive our latest updates & additional resources that could help your patients.

By submitting this form, you consent to Akili processing your data or personal information in accordance with our Privacy Notice and agree to the Terms of Use of our sites.


Indications, Safety and Cautions

EndeavorRx is a digital therapeutic indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Patients who engage with EndeavorRx demonstrate improvements in a digitally assessed measure, Test of Variables of Attention (TOVA®), of sustained and selective attention and may not display benefits in typical behavioral symptoms, such as hyperactivity. EndeavorRx should be considered for use as part of a therapeutic program that may include clinician-directed therapy, medication, and/or educational programs, which further address symptoms of the disorder.

No serious adverse events were reported. Of 538 participants in trials supporting EndeavorRx authorization, 50 participants (9.3%) experienced treatment-related adverse events (probable, likely), and three participants experienced treatment-related adverse events with the digital control, in studies where a control was used. Associated adverse events included frustration (6.1%), headache (1.3%), dizziness (0.6%), emotional reaction (0.4%), nausea (0.4%), and aggression (0.2%). All adverse events were generally transient. Only 3 events led to device discontinuation, and no subject reported lasting or irreversible effects after discontinuation.

Rx only: Federal law restricts this device to sale by or on the order of a licensed health care provider. EndeavorRx should only be used by the patient for whom the prescription was written. For medical questions, please contact your child’s healthcare provider. If you are experiencing a medical emergency, please dial 911. EndeavorRx is not intended to be used as a stand-alone therapeutic and is not a substitution for your child’s medication.

If your child experiences frustration, emotional reaction, dizziness, nausea, headache, eye-strain, or joint pain while playing EndeavorRx pause the treatment. If the problem persists contact your child’s healthcare provider. If your child experiences a seizure stop the treatment and contact your child’s healthcare provider.

EndeavorRx may not be appropriate for patients with photo-sensitive epilepsy, color blindness, or physical limitations that restrict use of a mobile device; parents should consult with their child’s healthcare provider.

Please follow all of your mobile device manufacturer’s instructions for the safe operation of your mobile device. For example, this may include appropriate volume settings, proper battery charging, not operating the device if damaged, and proper device disposal. Contact your mobile device manufacturer for any questions or concerns that pertain to your device.